Chase Knickerbocker's Stock Ratings

Craig-Hallum Analyst

Chase Knickerbocker is an analyst at Craig-Hallum. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

-5.95%

Smart Score

39.3%

Overall Average Return Percentile

26th

Number of Ratings

15
Buy NowGet Alert
05/15/2024FENCBuy Now
Fennec Pharmaceuticals
$6.78150.74%$20 → $17MaintainsBuyGet Alert
05/10/2024IRWDBuy Now
Ironwood Pharmaceuticals
$6.30122.22%$18 → $14MaintainsBuyGet Alert
05/09/2024AVDLBuy Now
Avadel Pharmaceuticals
$15.9544.2%$22 → $23MaintainsBuyGet Alert
05/06/2024ETONBuy Now
Eton Pharmaceuticals
$3.60122.22% → $8Initiates → BuyGet Alert
04/03/2024INDVBuy Now
Indivior
$18.46100.43% → $37Initiates → BuyGet Alert
03/18/2024FENCBuy Now
Fennec Pharmaceuticals
$6.78165.49%$17 → $18MaintainsBuyGet Alert
03/05/2024AVDLBuy Now
Avadel Pharmaceuticals
$15.9537.93%$20 → $22MaintainsBuyGet Alert
02/07/2024ACSTBuy Now
Acasti Pharma
$2.99100.67% → $6Initiates → BuyGet Alert
01/17/2024IRWDBuy Now
Ironwood Pharmaceuticals
$6.30233.33% → $21Initiates → BuyGet Alert
10/27/2023MDXGBuy Now
MiMedx Group
$7.1567.83% → $12Initiates → BuyGet Alert
09/07/2023SCPHBuy Now
scPharmaceuticals
$3.91411.51% → $20Initiates → BuyGet Alert
07/11/2023XTNTBuy Now
Xtant Medical Hldgs
$0.7266.67%$1 → $1.2MaintainsBuyGet Alert
04/26/2023XTNTBuy Now
Xtant Medical Hldgs
$0.7238.89% → $1Initiates → BuyGet Alert
03/13/2023PHATBuy Now
Phathom Pharmaceuticals
$9.42122.93% → $21Initiates → BuyGet Alert
08/08/2022FENCBuy Now
Fennec Pharmaceuticals
$6.78106.49% → $14Assumes → BuyGet Alert